Mesoblast Limited

About Mesoblast Limited

The vision for Mesoblast – to become the world leader in novel therapeutic approaches for patients with bone and joint diseases, including adult stem cell therapy for bone fractures and spinal disease, and for regeneration of damaged joint cartilage and intervertebral discs.

• Adult
• -
• Arteries
• -
• Asx
• -
• Biotechnology
• -
• Blood
• -
• Bone Fractures
• -
• Cartilage
• -
• Cell Therapy
• -
• Cells
• -
• Discs
• -
• Disease
• -
• human
• -
• Infection
• -
• JOINT DISEASES
• -
• Joints
• -
• Knee
• -
• muscle
• -
• orthopedic
• -
• osteoarthritis
• -
• Peripheral
• -
• Publications
• -
• scientific
• -
• Skin
• -
• Stem Cell
• -
• Stem Cell Therapy
• -
• Surgery Heart
• -
• Technology
• -
• Vessels

Mesoblast Commences Bone Regeneration Trials at Colorado State University 17-Sep-2005

Australian adult stem cell company, Mesoblast Limited (ASX:MSB), today announced it had commenced pre-clinical trials at Colorado State University in support of its Investigational New Drug (IND) submissions to the United States Food & Drug Administration (FDA). Find More